X4 Pharmaceuticals Q3 EPS $(0.69) Beats $(0.82) Estimate, Sales $1.765M Miss $1.901M Estimate

X4 Pharmaceuticals (NASDAQ:XFOR) reported quarterly losses of $(0.69) per share which beat the analyst consensus estimate of $(0.82) by 15.85 percent. This is a 87.41 percent increase over losses of $(5.48) per share from the same period last year. The company reported quarterly sales of $1.765 million which missed the analyst consensus estimate of $1.901 million by 7.17 percent. This is a 215.18 percent increase over sales of $560.000 thousand the same period last year.